MSB 3.21% $1.13 mesoblast limited

Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?, page-59

  1. 1,465 Posts.
    lightbulb Created with Sketch. 347
    Reckon you're spot on mate, and I don't believe we will see anything until 1st October our time. IMO it certainly will not be early, as this approval would open up a whole new world of possibilities in medicinal treatments. If I was the FDA I wouldn't want to be seen rushing.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.